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Objectives: There is a lack of international unification for AST methodology for Legionella pneumophila. Current
literature contains multiple possible methods and this study compares each of them to determine methodo-
logical concordance.
Methods: Antibiotic susceptibility of 50 L. pneumophila strains was determined using broth microdilution (BMD),
serial antimicrobial dilution in traditional buffered charcoal yeast extract (BCYE) agar (as well as comparison
with gradient strip overlay on BCYE) and in a novel charcoal-free agar (LASARUS) for rifampicin, azithromycin,
levofloxacin and doxycycline.
Results: The deviation of tested media relative to BMD highlighted the overall similarity of BMD and LASARUS
across all antimicrobials tested (within one serial dilution). BCYE agar dilution showed an increased MIC of up to
five serial dilutions relative to BMD, while MICs by gradient strip overlay on BCYE were elevated by two to three
serial dilutions, with the exception of doxycycline, which was decreased by three serial dilutions relative to
MIC values determined by BMD. The MIC range for azithromycin was wider than for other antimicrobials tested
and found to be caused by the presence or absence of the lpeAB gene.
Conclusions: BMD-based antimicrobial susceptibility testing (AST) methodology should be the internationally
agreed gold standard for Legionella spp. AST, as is common for other bacterial species. Traditional BCYE gave sig-
nificantly elevated MIC results and its use should be discontinued for Legionella spp., while MIC determination
using LASARUS solid medium gave results concordant (within one serial dilution) with BMD for all antimicrobials
tested. To the best of our knowledge, this study is the first to identify the lpeAB gene in UK isolates.
Introduction
Legionella pneumophila (and to a lesser extent other Legionella
spp.) causes Legionnaires’ disease (LD), a serious community-
acquired pneumonia (CAP) with a mortality rate up to 10%.1
Screening for infection with L. pneumophila predominantly relies
upon urinary antigen testing (UAT), which detects Legionella LPS in
urine and is confirmed by culture of lower respiratory samples on
media such as BCYE (buffered charcoal yeast extract) or by mo-
lecular detection methods.
Both the NICE and British Thoracic Society therapeutic guide-
lines recommend amoxicillin combined with a macrolide for
patients with moderate-severity CAP while those with high-
severity CAP should be treated with dual combination anti-
microbials comprising a b-lactamase-stable b-lactam (such as
co-amoxiclav) and a macrolide.2 However, monotherapeutic
antimicrobial intervention is common as initial empirical therapy
in patients with low-severity CAP and can include amoxicillin, cla-
rithromycin, doxycycline and levofloxacin as the recommended
first-line therapeutic agents.2,3 Tetracyclines, fluoroquinolones
and other macrolides have been reported as potentially effective
treatments.4 Identification of antibiotic resistance mechanisms in
Legionellaceae is enabling detection and characterizing the emer-
gence of reduced sensitivity in strains, demonstrated by increasing
detection of the lpeAB macrolide efflux pump5 and character-
ization of tetracycline deconstructase genes in Legionella
longbeachae (more prevalent than L. pneumophila in CAP in
Australia).6 Understanding mechanisms of resistance is of
particular importance for Legionellaceae wherein delay in cor-
rect effective therapy is associated with significant increase in
morbidity and mortality.7
VC The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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Currently, there is no international consensus on antimicrobial
susceptibility testing (AST) methodology for systematic investiga-
tion of Legionella spp. A variety of methodologies to determine
MICs for target antimicrobials are available. The gold standard
method for most clinically relevant bacterial pathogens is broth
microdilution (BMD).
International standardization via CLSI, EUCAST or other refer-
ence centres requires several conditions to be met: (i) standardiza-
tion to a defined bacterial inoculum load; (ii) a defined growth
medium (either commercially available from more than one
source or constituents fully specified); (iii) standardized dilutions of
defined (relevant) antimicrobials (or defined concentrations for
disc diffusion); and (iv) AST to be validated by concurrent testing of
universally available (ATCC-, DSMZ- and/or NCTC-deposited) bac-
terial prototype strains (both defined sensitive and resistant
strains). There are often a number of other surrogate methods
(commercial and non-commercial) for AST determination of fas-
tidious and non-fastidious bacterial pathogens; however, these
are validated against BMD using internationally accepted refer-
ence methods and organisms to attain ISO and IVD standards.
The term ‘epidemiological cut-off’ (ECOFF) is defined as the in vitro
MIC threshold that allows the discrimination of WT strains from
those with acquired resistance mechanisms.8 To date, there are no
ECOFF values appointed for Legionella spp., due in part to the vari-
ation in MIC values when compared with different methodologies.
For Legionella spp. AST, BMD is time-consuming and difficult to
run on multiple isolates due to slower growth rates and complex
enriched medium requirements. Solid-based methods have been
limited by the required inclusion of activated charcoal to remove
growth-inhibitory toxins arising from autoclaved agar. The degree
of antimicrobial compound adsorption is unknown and likely to be
highly variable, with the consequence of elevating the MIC.9,10
Antimicrobials can either be incorporated directly into the solid
agar (as a range of dilutions) or applied on poured plates by over-
laying commercial antimicrobial gradient strips. The standard
Kirby–Bauer disc diffusion method (inhibition zones around paper
discs impregnated with antimicrobials) cannot be interpreted
without definition of accepted zone diameters for reduced sensi-
tivity.11 Significant discrepancies between MICs determined using
BMD methods and BCYE have been noted previously.9,10 However,
no study has performed a systematic comparison between BMD
and BCYE media. This limits the currently available data for inter-
national reference by EUCAST, with current data based solely on
antimicrobial gradient strips (such as Etests) on BCYE. Before
ECOFF values can be established, unification of the existing data in
the literature, through cross-comparison of shortfalls and inherent
variability relative to the gold standard (BMD) utilized for other bac-
terial species, is required as the first step to agreeing international
guidelines for AST in Legionellaceae.
This study describes the comparison of MICs determined for a
panel of 50 L. pneumophila strains consisting of 35 Welsh clinical
and environmental isolates, combined with 5 strains from a previ-
ously published BMD study12 and 10 National Collection of Type
Cultures (NCTC) control strains, comparing BMD and BCYE (anti-
microbial gradient strips and dilution of antimicrobials in agar)
with a novel commercially available charcoal-free Legionella
Antimicrobial Susceptibility And Resistance Universal Screening
medium (LASARUS). Here we provide a basis for future studies to
define ECOFF values to enable internationally agreed and defined
resistance breakpoints for Legionellaceae.
Materials and methods
Reference cohort
Fifty L. pneumophila strains previously archived at PHE were included in the
study: 22 clinical strains from Wales; 13 environmental strains from Wales;
5 previously reported strains from England;12 and 10 NCTC reference strains
of L. pneumophila (Table S1, available as Supplementary data at JAC
Online).
Antimicrobial sensitivity materials
Antimicrobials used in this study included rifampicin (Sigma–Aldrich, Poole,
UK), levofloxacin hydrochloride (Sigma–Aldrich), doxycycline hydrochloride
(Sigma–Aldrich) and azithromycin (Aspire Pharma, UK). All working stocks
were made fresh at a concentration of 2560 mg/L in 10 mL. For rifampicin,
25.6 mg was dissolved in 1 mL of DMSO initially, prior to addition to 9 mL
H2O. Doxycycline, levofloxacin and azithromycin were reconstituted initially
at 100 mg/mL, as per the manufacturers’ instructions, before dilution in
H2O to working stocks.
The three culture media used in this study were prepared according to
either the manufacturers’ instructions or previously published papers:
BMD5, LASARUS (Instant Test Ltd, UK) and BCYE agar and supplement
(Sigma–Aldrich). All media were supplemented with 400 mg/L of L-cysteine
(Sigma–Aldrich).
Preparation of strains and antimicrobial-containing
solid media
Isolates were initially revived from frozen archives by subculture onto BCYE
plates and incubated in a humidified atmosphere at 37C for 120 h. Single
colonies were picked and resuspended in sterile 3 mL H2O (Thermo Fisher
Scientific, USA) at a concentration equivalent to 0.5 McFarland (expected to
produce an inoculum of approximately 1.5%108 cfu/mL). A 0.2 mL 1:10 di-
lution of the 0.5 McFarland solution was made for each isolate suspension
and placed in a 96-well cell culture plate (Greiner Bio-One, Germany); a new
96-well cell culture plate was made up for each tested medium and
antimicrobial.
Antimicrobials were added just prior to plate-pouring into 100 mm
square plates (Sarstedt, Germany) for BCYE and LASARUS solid media
(one antimicrobial, one concentration per plate). For BMD, antimicro-
bials were mixed with buffered yeast extract broth containing 0.1%
a-ketoglutarate (BYEa)5 and 0.2 mL was placed into each well of a ster-
ile 96-well plate.
All media containing the test range of antimicrobials (and an
antimicrobial-free growth control) were inoculated from a standardized in-
oculation plate using a multipoint inoculator (MAST URIV
R
DOT, Mast Group,
UK) (Figure S1). Multipoint inoculator pins were sterilized in 80% ethanol for
10 min between ranges of a specific antimicrobial and between media
types. Plates were incubated as above and read after 120 h. Isolates were
tested in quadruplet.
Antimicrobial gradient strip test
Antimicrobial gradient strips (Etest, bioMérieux, France) were overlaid on a
fresh bacterial lawn (0.1 mL from a 0.5 McFarland suspension) on BCYE
agar. Plates were incubated as above and read at 48, 72 and 120 h with
MICs determined as the lowest concentration of antimicrobial that inhibited
growth.
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Evaluation of Legionella growth on LASARUS
A subset of 12 NCTC strains (Table 1) were evaluated by doubling dilution
(standardized by multipin inoculation on replicate plates between media
types) to compare the sensitivity of L. pneumophila growth detection on
LASARUS with that on BCYE. Solid media were inoculated with the dilution
series for each strain and the highest dilution showing clear bacterial
growth in a humidified incubator at 37C after 72 and 120 h was recorded
(Figure 1). Values for the highest dilution were compared by paired t-test
analysis using GraphPad Prism (v7.03) and P < 0.05 was set as the threshold
for statistical significance.
WGS
Twelve isolates showing high and 18 isolates showing low azithromycin
MIC values were suspended in H2O, heat-inactivated at 95C for 30 min
and pelleted. Genomic DNA was extracted using the QIAamp DNA
Mini Kit (QIAGEN, Germany), with an additional RNAse step, on the
automated QIAcube platform (QIAGEN). Genomic DNA was quantified
using the Qubit fluorometer 4.0 and the dsDNA 1X Kit (Thermo Fisher
Scientific). Genomic libraries were prepared using Nextera XT v2
(Illumina, USA), with a bead-based normalization, following manufac-
turer guidelines. Paired-end WGS was performed on an Illumina MiSeq
using the v3 chemistry to generate fragment lengths up to 300 bp
(600 cycles).
Bioinformatics analysis
Bioinformatics analysis was performed using a high-performance comput-
ing cluster at Cardiff University (ARRCA) and CLIMB.13 Paired-end reads
(FASTQ) were subjected to quality control checks before downstream ana-
lysis. Trim Galore (v0.4.3)14 was used to remove the Nextera adapter
sequences and low-quality bases. Reports before and after read-trimming
were generated using FASTQC (v0.11.2)15 and collated using MultiQC
(v1.7).16 The mean read length and number of sequences provided on the
MultiQC reports was used to determine sequencing coverage. Paired-end
reads were overlapped using FLASH (v1.2.11)17 and assembled into contigs
using SPAdes (v3.9.0).18 The trimmed FASTQ reads were mapped to the
contigs using BWA (v.0.7.15)19 and SAMtools (v1.3.1).20 Pilon (v1.22)21 was
used to assess any misassemblies/errors in base-calling in the resulting
mapped BAM file. All assemblies were performed within Shovill (v0.9.0).
Final genome assembly metrics were generated using QUAST (v.2.1).22
Antibiotic resistance and plasmid genomic profiles were characterized
using ABRicate and associated databases: ResFinder23 and
PlasmidFinder.24 Genomes were identified using Pathogenwatch and anno-
tated using Prokka (v1.12).25 Further analysis was carried out using
Geneious sequence analysis software (vR10; Biomatters Ltd, New Zealand).
Sequences were uploaded to ENA-EMBL and assigned the accession
number PRJEB40430.
Statistical analysis
Prism GraphPad (v7.03) was used for t-test analysis.
Ethics
Ethical approval was not required. All studies were performed on archived
bacterial isolates, blinded to the clinical details of the patients from which
the isolates were obtained, other than that the samples had originally been
referred from a Welsh hospital or a PHE collection (not relevant for NCTC
reference strains).
Results
Comparison of growth potential between BCYE and
LASARUS agars
Prior to comparison of MIC determination, the relative capacity of
the two solid media to support bacterial growth was established
by the relative ability to detect growth following serial 2-fold dilu-
tion of 12 NCTC reference strains (Figure 1). LASARUS and BCYE
Table 1. NCTC L. pneumophila strains used for comparison of BCYE and
LASARUS growth
NCTC number Strain designation Serogroup
11230 Togus-1 2
11232 Bloomingtion-2 3
11233 Los Angeles-1 4
11406 Chicago-2 6
11984 Chicago-8 7
11985 Concord-3 8
12000 Leiden-1 10
12006 Benidorm 030E 1
12008 Olda 1
12179 797-PA-H 11
12181 13
12286 Knoxville-1 1
25
LASARUS
BCYE20
15
N
um
be
r o
f 2
-f
ol
d 
di
lu
tio
ns
10
5
0
NC
TC
 12
28
6
NC
TC
 12
00
6
NC
TC
 12
00
8
NC
TC
 11
23
0
NC
TC
 11
23
2
NC
TC
 11
23
3
NC
TC
 11
40
6
NC
TC
 11
98
4
NC
TC
 12
18
1
NC
TC
 12
17
9
NC
TC
 12
00
0
NC
TC
 11
98
5
Figure 1. Growth comparison of 12 isolates in triplicate against BCYE showing similar growth patterns (P > 0.99).
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were highly comparable in their relative ability to support growth
that could be easily visualized.
Comparison of four methodologies for MIC
determination: BMD, Etest (BCYE) and solid agar
(LASARUS, BCYE)
There was close concordance between liquid (BYEa) medium and
LASARUS agar for the determination of rifampicin MIC (Figure 2),
levofloxacin MIC (Figure 3) and azithromycin MIC (Figure 4); thresh-
olds of inhibition were found to be moderately elevated for gradi-
ent strip tests on BCYE and remarkably elevated in BCYE agar
dilution.
MIC50 and MIC90 values for rifampicin determined on LASARUS
or by BMD with BYEa were 0.004 and 0.008 mg/L, respectively.
Values for gradient strip tests gave an MIC50 of 0.032 mg/L and an
MIC90 of 0.032 mg/L, while BCYE agar dilution values were elevated
16-fold to MIC50 = 0.06 mg/L and MIC90 = 0.128 mg/L (Figure 2).
Similarly, levofloxacin MIC values determined on LASARUS
and by BMD with BYEa were identical, with both having
MIC50 = 0.03 mg/L and MIC90 = 0.03 mg/L, compared with 32-
fold higher values of MIC50 = 1 mg/L and MIC90 = 1 mg/L for
BCYE, while gradient strip tests gave intermediate but still ele-
vated values of MIC50 = 0.064 mg/L and MIC90 = 0.128 mg/L
(Figure 3).
Relative to other tested antimicrobials, substantially higher con-
centrations of doxycycline were required to inhibit the growth of
the 50 isolates of L. pneumophila (Figure 4) and the MICs were
similar for all four methods: BYEa and LASARUS (MIC50 = 16 mg/L
and MIC90 = 32 mg/L); BCYE agar (MIC50 = 32 mg/L and
MIC90 = 32 mg/L); and reduced MIC for gradient strip tests
(MIC50 = 2 mg/L and MIC90 = 4 mg/L).
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Figure 2. Rifampicin MIC determination for 50 L. pneumophila. Antimicrobials were diluted in liquid BYEa (grey; reference BMD method) and com-
pared with solid media LASARUS (yellow with black stripe) and BCYE (agar dilution, black; gradient strip, white). Data represent the mean ± SD for four
replicates. Gradient strips were replicated in triplicate. This figure appears in colour in the online version of JAC and in black and white in the print ver-
sion of JAC.
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Figure 3. Levofloxacin MIC determination for 50 L. pneumophila. Antimicrobials were diluted in liquid BYEa (grey; reference BMD method) and com-
pared with solid media LASARUS (yellow with black stripe) and BCYE (agar dilution, black; gradient strip, white). Data represent the mean ± SD for four
replicates. Gradient strips were replicated in triplicate. This figure appears in colour in the online version of JAC and in black and white in the print ver-
sion of JAC.
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The MIC ranges for these three antimicrobials showed little
variance, generally entirely contained within a range of three to
four serial dilutions for all isolates. However, a greater strain-to-
strain MIC variation was observed for azithromycin (Figure 5).
Overall concordant values were again observed for LASARUS
and BYEa (MIC50 = 0.032 mg/L and MIC90 = 0.064 mg/L) relative
to significantly increased BCYE MIC values (MIC50 = 0.256 mg/L
and MIC90 = 0.256 mg/L) and intermediately elevated values
for gradient strip tests (MIC50 = 0.064 mg/L and MIC90 =
0.128 mg/L).
Comparison of MIC modal deviation of LASARUS, BCYE
agar dilution and gradient strip test from gold standard
BMD
When considering BMD with BYEa as the gold standard, the aver-
age modal deviation of other tested media against this highlights
the overall similarity of BMD and LASARUS, within one serial dilu-
tion deviation, and highlights the inaccuracy of BCYE, with an MIC
increase of up to five serial dilutions above the gold standard.
Gradient strip tests on BCYE were again elevated, showing two to
three serial dilution deviations from BYEa BMD.
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Figure 4. Doxycycline MIC determination for 50 L. pneumophila. Antimicrobials were diluted in liquid BYEa (grey; reference BMD method) and com-
pared with solid media LASARUS (yellow with black stripe) and BCYE (agar dilution, black; gradient strip, white). Data represent the mean ± SD for four
replicates. Gradient strips were replicated in triplicate. This figure appears in colour in the online version of JAC and in black and white in the print ver-
sion of JAC.
0
10
20
30
40
LASARUS
BYE-a
BCYE
Gradient strip
0.008 0.016 0.03 0.06 0.125 0.25 0.5
Azithromycin concentration (mg/L)
N
um
be
r o
f s
tr
ai
ns
Figure 5. Azithromycin MIC determination for 50 L. pneumophila. Antimicrobials were diluted in liquid BYEa (grey; reference BMD method) and com-
pared with solid media LASARUS (yellow with black stripe) and BCYE (agar dilution, black; gradient strip, white). Data represent the mean ± SD for four
replicates. Gradient strips were replicated in triplicate. This figure appears in colour in the online version of JAC and in black and white in the print ver-
sion of JAC.
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WGS analysis of azithromycin-susceptible and -resistant
strain subsets
WGS was performed on isolates at the maximal and minimal ends
of the azithromycin susceptibility range to determine the presence
of known mechanisms of reduced susceptibility (sequencing met-
rics are summarized in Table S2). Five mechanisms of macrolide
antimicrobial resistance were explored by examining the WGS
results for the strains of L. pneumophila. Macrolide resistance-
mediating mutations in the 23S rRNA gene were difficult to assess
due to the presence of three separate operons in all strains exam-
ined; however, no mutations or sequence heterogeneity at pos-
ition 2058 or 2059 (Escherichia coli numbering) of the rrl gene were
identified. Furthermore, no mutations in the ribosomal accessory
protein genes rplD (protein L4) and rplV (protein L22) were found.
The 23S rRNA methylase genes erm(A), erm(B), erm(C) and erm(F),
the macrolide phosphotransferase gene mph(A) and the macro-
lide esterase genes ere(A) and ere(B) were not observed in any of
the strains. Furthermore, no presence of the efflux pump genes
mef(A/E) was observed in any of the strains. Analysis of isolates
with MIC > 0.06 mg/L using BYEa or LASARUS media revealed 5/10
L. pneumophila strains contained the lpeAB efflux pump gene.26 Of
the 18 isolates with MIC < 0.016 mg/L (tested on BYEa or LASARUS)
that were sequenced, none contained the lpeAB efflux pump gene.
Discussion
Current guidance from EUCAST recommends users should deter-
mine MICs using antimicrobial gradient strips on BCYE for
Legionellaceae. ECOFF levels have not been assigned and there is
an absence of agreed international guidelines to determine the
resistance of any clinical or environmental Legionella spp. This has
resulted in multiple methodologies, providing a wide range of
results in the literature. Without standardization, this continues
to confound the definition between antimicrobial resistance and
sensitivity for this species.
In line with other bacterial pathogens, we utilized BYEa BMD as
the gold standard MIC methodology, which gave concordant MICs
with serial agar dilution in LASARUS. Gradient strips gave the next
closest, but moderately elevated, MIC values; however, serial anti-
microbial dilution in BCYE agar gave highly discordant and elevated
MICs, with greater variability in the MIC range determined.
Unfortunately, gradient strips are incompatible with the formula-
tion of LASARUS plates (based on triplicate attempts to utilize
gradient strips on L. pneumophila lawns grown on LASARUS). With
every attempt, the zone of inhibition extended well beyond
the boundaries of the strip. On LASARUS, extensive antibiotic diffu-
sion occurred irrespective of humification of incubation. For each of
these experiments, gradient strips from the same batch overlaid
on L. pneumophila-inoculated BCYE plates, run in parallel,
performed as expected. Why LASARUS has increased diffusion
capacity is not clear and could be due to moisture content in the
formulation promoting diffusion or another mechanism.
Interestingly, the chelating effect of activated charcoal, elevating
MIC determination, has been reported previously9,10,27 and, while
acknowledged, it has generally been disregarded as a problem in
the absence of solid culture media without charcoal, despite
the impact on accuracy of results. Garcia et al.11 found similarly
discrepant MICs when comparing antimicrobial dilution series in
liquid BYEa with incorporation into solid BCYE.
When evaluating an individual medium, all of our isolates were
inhibited within a distribution of 3- to 6-fold dilutions, similarly to
previous authors,9 thereby showing relatively little overall isolate
variation within this dataset. However, when comparing combined
data across all four methodologies in this study, the MIC distribu-
tion ranged across 6–9 serial dilutions due to the wide disparity
within the four investigated methods (Figure 6). This highlights the
importance of this systematic comparison, with methodologies
giving widely discordant results, especially those acquired by serial
agar dilution in BCYE.
Beyond the advantages of being able to perform high-
throughput testing on a solid medium with multipoint inoculation,
the translucent nature of LASARUS agar gave the additional ad-
vantage of safety for reading results, as opaque BCYE and 96-well
plates for BMD require removal of lids to determine culture growth
due to condensation. LASARUS agar would also therefore be
amenable to measurement using automated optical systems,
allowing increased throughput. BMD-based methodologies are
uniformly defined as the gold standard reference methodology for
the determination of MIC for most other bacterial species (e.g. CLSI
guidelines M100, M43A, etc.). However, in practice, BMD is labour-
intensive and assays requiring incubation for24 h impart a much
greater risk of interference by contamination relative to other bac-
teria that can be evaluated after 16–24 h of growth. Furthermore,
the slower growth rate of Legionellaceae and manual determin-
ation of turbidity to confirm growth adds a greater degree of
subjectivity for this bacterial species when performing AST.
Levofloxacin MICs investigated through BMD reported by Higa
et al.28 showed a similar range of 0.004–0.125 mg/L, compared
with our findings of 0.008–0.125 mg/L for BMD and 0.008–
0.06 mg/L for LASARUS. Our MICs determined by gradient strips
were moderately elevated in comparison (MIC50 = 0.125 mg/L;
MIC90 = 0.25 mg/L), but these were similar to values determined by
Sharaby et al.29 using the gradient strips, with MIC50 = 0.075 mg/L
0 +1 +2 +3 +4 +5–5 –4 –3 –2 –1
Rifampicin
LASARUS
BCYE agar
Gradient strip
Azithromycin
LASARUS
BCYE agar
Gradient strip
Levofloxacin
LASARUS
BCYE agar
Gradient strip
Doxycycline
LASARUS
BCYE agar
Gradient strip
Figure 6. Forest plot showing the mode of deviation of MIC when com-
pared with gold standard BYEa broth. !1 equals one serial dilution above
the modal average for BYEa BMD. LASARUS, yellow star; BCYE agar, black
circle; gradient strip, green square. This figure appears in colour in the on-
line version of JAC and in black and white in the print version of JAC.
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and MIC90 = 1 mg/L. Furthermore, while our MICs were significantly
elevated for BCYE agar dilution compared with all three presented
methodologies with MIC50 = 1 mg/L and MIC90 = 2 mg/L, these
results are still similar to the results reported by Martin et al.30 who
showed MIC50 = 1 mg/L for 41 Legionella spp. by BCYE serial dilution
methods.
MIC determination for rifampicin by gradient strip tests carried
out by Marques and Piedade31 showed MIC50 = 0.023 mg/L, con-
cordant with the values obtained using gradient strips in this study
(MIC50 = 0.016 mg/L). Agar dilution on BCYE of only 30 Legionella
strains carried out by Edelstein32 showed MIC ranges between
0.03 and 0.06 mg/L, falling within those found in this study (0.016–
0.125 mg/L). Reported BMD ranges for rifampicin vary from
0.00012 to 0.03 mg/L across three different publications5,12,33 and
Gomez-Lus et al.33 showed MIC50 = 0.004 mg/L for 140 Legionella
spp., identical to our findings.
MICs reported for doxycycline gradient strips against 32
isolates32 showed similar MIC50 and MIC90 values of 2 and 3 mg/L,
respectively, compared with our MIC50 = 2 mg/L and MIC90 = 4
mg/L. The authors noted an increase in MIC during incubation on
BCYE from 8 mg/L at 48 h to 32 mg/L at 72 h, highlighting potential
stability of some antimicrobials leading to variation of method-
ology used and the importance of standardization. The unusual
finding in this study was that doxycycline MICs were lower for gra-
dient strips than all other methodologies, in contrast to findings for
all other antimicrobials we tested, and this could be due to reduced
dispersion of doxycycline in the media, which was previously
hypothesized by Isenman et al.34 for tetracycline.
Azithromycin MICs on BCYE by gradient strips in this study
showed MIC50 = 0.064 mg/L and MIC90 = 0.125 mg/L, comparable
to MIC50 = 0.047 mg/L and MIC90 = 0.25 mg/L for 100 isolates from
Italy35 and ranges reported by others, including 0.016–4 mg/L and
0.06–4 mg/L.5,36 Further, the BMD MIC range of 0.008–0.125 mg/L
in this study was similar to that reported by Sharaby et al.29 who
found an MIC range of 0.038–1 mg/L. The greater MIC range for
azithromycin (relative to the tight ranges for other antimicrobials)
is routinely reported and can be explained by the gene lpeAB.5,37
Consistent with this finding, lpeAB was present in 5/10
L. pneumophila isolates with MICs above 0.06 mg/L in our study
and completely absent from all sequenced strains (n = 18) that
had MICs below 0.016 mg/L (isolate distribution consistent for
both BMD and LASARUS methodologies). To the best of our know-
ledge, this is the first identification of this gene conferring
decreased susceptibility to azithromycin in L. pneumophila isolates
from England and Wales.
Conclusions
BMD-based AST methodology should be the internationally agreed
gold standard for the determination of MIC for Legionella spp. This
method is well established for multiple bacterial pathogens, con-
ferring accurate inoculum concentration and resultant MIC.
Agreed medium formulation, incubation length and inclusion of
ATCC/NCTC-deposited reference strains should be included in the
international standardization of methodology.
The use of serial agar dilution using BCYE or gradient strip over-
lay on BCYE gave significantly elevated and more variable MIC
results than gold standard BMD and therefore should be discontin-
ued for Legionella spp. MIC determination. However, for ease of
use and adaptation to automation, the new commercially avail-
able LASARUS solid medium was the only method that gave
results concordant to within one serial dilution of BMD for all anti-
microbials tested. Therefore, AST determination by antimicrobial
agar dilution in LASARUS should be considered to have equal
validity to BMD methodologies.
To the best of our knowledge, this study is the first to identify
the lpeAB gene in isolates from England and Wales and confirmed
that the presence of this gene consistently decreased susceptibility
to azithromycin in L. pneumophila isolates. This supports sus-
ceptibility determination in cases with persistent infection and for
continued surveillance to identify emerging resistance trends in
L. pneumophila. However, the absence of international guidelines
and breakpoints for Legionella spp. makes routine MIC determin-
ation in clinical cases difficult to interpret and urgently requires
international consensus.
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